Florida Orthopaedic Institute   Report issue

Academic/Hospital Phase 1 Phase 3 Phase 4
Founded: Brandon FL United States (1989)

Organization Overview

First Clinical Trial
2019
NCT04169269
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Florida Orthopaedic Institute

Active Ingredients

Drugs in Phase 4 Trials (2)

enoxaparin (lovenox) (1 trial)

rivaroxaban (xarelto) (1 trial)

Drugs in Phase 3 Trials (1)

collagenase clostridium histolyticum (xiaflex) (1 trial)

Drugs in Phase 1 Trials (2)

bupivacaine (Exparel) (1 trial)

triamcinolone (kenalog) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Thromboembolism (Phase 4)

Thrombosis (Phase 4)

Venous Thromboembolism (Phase 4)

Venous Thrombosis (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 5